MicroRNA miR-150 is involved in Vα14 invariant NKT cell development and function

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2118-2126

  Zheng, Quanhui ^a   Zhou, Li ^a   Mi, Qing Sheng ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MICRORNA; MICRORNA 150; PROTEIN C MYB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE DELETION; GENE EXPRESSION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; THYMUS; UPREGULATION; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; NATURAL KILLER T-CELLS; PROTO-ONCOGENE PROTEINS C-MYB; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; UP-REGULATION;

EID: 84857466240     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103342     Document Type: Article

References (58)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336. (Pubitemid 46697911)
2. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1- specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562.
3. Ho, E. L., L. N. Carayannopoulos, J. Poursine-Laurent, J. Kinder, B. Plougastel, H. R. Smith, and W. M. Yokoyama. 2002. Costimulation of multiple NK cell activation receptors by NKG2D. J. Immunol. 169: 3667-3675.
4. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716. (Pubitemid 40814501)
5. Dellabona, P., E. Padovan, G. Casorati, M. Brockhaus, and A. Lanzavecchia. An invariant Valpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 180: 1171-1176.
6. Tilloy, F., E. Treiner, S. H. Park, C. Garcia, F. Lemonnier, H. de la Salle, A. Bendelac, M. Bonneville, and O. Lantz. 1999. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J. Exp. Med. 189: 1907-1921. (Pubitemid 29295889)
7. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971-978. (Pubitemid 32976171)
8. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555. (Pubitemid 34408679)
9. Pellicci, D. G., K. J. Hammond, A. P. Uldrich, A. G. Baxter, M. J. Smyth, and D. I. Godfrey. 2002. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844. (Pubitemid 34286755)
10. Matsuda, J. L., Q. Zhang, R. Ndonye, S. K. Richardson, A. R. Howell, and L. Gapin. 2006. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 107: 2797-2805.
11. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169: 2397-2406. (Pubitemid 34920982)
12. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 3: 966-974. (Pubitemid 35154011)
13. Lantz, O., and A. Bendelac. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 180: 1097-1106. (Pubitemid 24256622)
14. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900. (Pubitemid 40563188)
15. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417. (Pubitemid 46780078)
16. Lehuen, A., J. Diana, P. Zaccone, and A. Cooke. 2010. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 10: 501-513.
17. Aktan, I., A. Chant, Z. D. Borg, D. E. Damby, P. C. Leenstra, G. W. Lilley, J. Petty, B. T. Suratt, C. Teuscher, E. K. Wakeland, et al. 2010. Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function. J. Immunol. 185: 144-156.
18. Tahir, S. M., O. Cheng, A. Shaulov, Y. Koezuka, G. J. Bubley, S. B. Wilson, S. P. Balk, and M. A. Exley. 2001. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J. Immunol. 167: 4046-4050. (Pubitemid 32910851)
19. Dhodapkar, M. V., M. D. Geller, D. H. Chang, K. Shimizu, S. Fujii, K. M. Dhodapkar, and J. Krasovsky. 2003. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J. Exp. Med. 197: 1667-1676. (Pubitemid 36745342)
20. Kovalovsky, D., E. S. Alonzo, O. U. Uche, M. Eidson, K. E. Nichols, and D. B. Sant'Angelo. 2010. PLZF induces the spontaneous acquisition of memory/ effector functions in T cells independently of NKT cell-related signals. J. Immunol. 184: 6746-6755.
21. Hu, T., A. Simmons, J. Yuan, T. P. Bender, and J. Alberola-Ila. 2010. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nat. Immunol. 11: 435-441.
22. Schwartzberg, P. L., K. L. Mueller, H. Qi, and J. L. Cannons. 2009. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol. 9: 39-46.
23. Cen, O., A. Ueda, L. Guzman, J. Jain, H. Bassiri, K. E. Nichols, and P. L. Stein. 2009. The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 14 transgenic NKT cells via effects on GATA-3 and T-bet expression. J. Immunol. 182: 1370-1378.
24. Elewaut, D., R. B. Shaikh, K. J. Hammond, H. De Winter, A. J. Leishman, S. Sidobre, O. Turovskaya, T. I. Prigozy, L. Ma, T. A. Banks, et al. 2003. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J. Exp. Med. 197: 1623-1633. (Pubitemid 36745338)
25. Winter, J., S. Jung, S. Keller, R. I. Gregory, and S. Diederichs. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11: 228-234.
26. Fedeli, M., A. Napolitano, M. P. Wong, A. Marcais, C. de Lalla, F. Colucci, M. Merkenschlager, P. Dellabona, and G. Casorati. 2009. Dicer-dependent microRNA pathway controls invariant NKT cell development. J. Immunol. 183: 2506-2512.
27. Zhou, L., K. H. Seo, H. Z. He, R. Pacholczyk, D. M. Meng, C. G. Li, J. Xu, J. X. She, Z. Dong, and Q. S. Mi. 2009. Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proc. Natl. Acad. Sci. USA 106: 10266-10271.
28. Seo, K. H., L. Zhou, D. Meng, J. Xu, Z. Dong, and Q. S. Mi. 2010. Loss of microRNAs in thymus perturbs invariant NKT cell development and function. Cell. Mol. Immunol. 7: 447-453.
29. Zhou, B., S. Wang, C. Mayr, D. P. Bartel, and H. F. Lodish. 2007. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 104: 7080-7085. (Pubitemid 47186012)
30. Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, and K. Rajewsky. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159. (Pubitemid 47498525)
31. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7: 1057-1062. (Pubitemid 32937388)
32. Bezman, N. A., T. Chakraborty, T. Bender, and L. L. Lanier. 2011. miR-150 regulates the development of NK and iNKT cells. J. Exp. Med. 208: 2717-2731.
33. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
34. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20: 477-494. (Pubitemid 38482125)
35. Chen, Y. H., N. M. Chiu, M. Mandal, N. Wang, and C. R. Wang. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-467. (Pubitemid 27208201)
36. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
37. Sakamoto, H., G. Dai, K. Tsujino, K. Hashimoto, X. Huang, T. Fujimoto, M. Mucenski, J. Frampton, and M. Ogawa. 2006. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood 108: 896-903. (Pubitemid 44154622)
38. Allen, R. D., III, T. P. Bender, and G. Siu. 1999. c-Myb is essential for early T cell development. Genes Dev. 13: 1073-1078. (Pubitemid 29233139)
39. Stanic, A. K., J. S. Bezbradica, J. J. Park, N. Matsuki, A. L. Mora, L. Van Kaer, M. R. Boothby, and S. Joyce. 2004. NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172: 2265-2273. (Pubitemid 38182374)
40. Vallabhapurapu, S., I. Powolny-Budnicka, M. Riemann, R. M. Schmid, S. Paxian, K. Pfeffer, H. Körner, and F. Weih. 2008. Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells. Eur. J. Immunol. 38: 3508-3519.
41. Ohteki, T., S. Ho, H. Suzuki, T. W. Mak, and P. S. Ohashi. 1997. Role for IL-15/ IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J. Immunol. 159: 5931-5935. (Pubitemid 127471528)
42. Ciprés, A., S. Gala, C. Martinez-A, I. Mérida, and P. Williamson. 1999. An IL-2 receptor beta subdomain that controls Bcl-X(L) expression and cell survival. Eur. J. Immunol. 29: 1158-1167. (Pubitemid 29164161)
43. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
44. Kim, P. J., S. Y. Pai, M. Brigl, G. S. Besra, J. Gumperz, and I. C. Ho. 2006. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177: 6650-6659.
45. Au-Yeung, B. B., and D. J. Fowell. 2007. A key role for Itk in both IFN gamma and IL-4 production by NKT cells. J. Immunol. 179: 111-119. (Pubitemid 46986524)
46. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076. (Pubitemid 37248622)
47. Tanaka, S., J. Tsukada, W. Suzuki, K. Hayashi, K. Tanigaki, M. Tsuji, H. Inoue, T. Honjo, and M. Kubo. 2006. The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells. Immunity 24: 689-701. (Pubitemid 43884897)
48. Bezbradica, J. S., L. E. Gordy, A. K. Stanic, S. Dragovic, T. Hill, J. Hawiger, D. Unutmaz, L. Van Kaer, and S. Joyce. 2006. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 25: 487-497. (Pubitemid 44354212)
49. Golay, J., G. Cusmano, and M. Introna. 1992. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol. 149: 300-308.
50. Pauza, C. D. 1987. Regulation of human T-lymphocyte gene expression by interleukin 2: immediate-response genes include the proto-oncogene c-myb. Mol. Cell. Biol. 7: 342-348. (Pubitemid 17230416)
51. Bender, T. P., C. S. Kremer, M. Kraus, T. Buch, and K. Rajewsky. 2004. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat. Immunol. 5: 721-729. (Pubitemid 39023304)
52. Maurice, D., J. Hooper, G. Lang, and K. Weston. 2007. c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. EMBO J. 26: 3629-3640. (Pubitemid 47236884)
53. Clarke, M. F., J. F. Kukowska-Latallo, E.Westin, M. Smith, and E. V. Prochownik. 1988. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8: 884-892. (Pubitemid 18044888)
54. Bartůnek, P., J. Králová, G. Blendinger, M. Dvorák, and M. Zenke. 2003. GATA- 1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene 22: 1927-1935. (Pubitemid 36523630)
55. Wu, Q., H. Jin, Z. Yang, G. Luo, Y. Lu, K. Li, G. Ren, T. Su, Y. Pan, B. Feng, et al. 2010. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem. Biophys. Res. Commun. 392: 340-345.
56. Lazarevic, V., A. J. Zullo, M. N. Schweitzer, T. L. Staton, E. M. Gallo, G. R. Crabtree, and L. H. Glimcher. 2009. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10: 306-313.
57. Zhou, L., X. Qi, J. A. Potashkin, F. W. Abdul-Karim, and G. I. Gorodeski. 2008. MicroRNAs miR-186 and miR-150 down-regulate expression of the proapoptotic purinergic P2X7 receptor by activation of instability sites at the 3′- untranslated region of the gene that decrease steady-state levels of the transcript. J. Biol. Chem. 283: 28274-28286.
58. Kawamura, H., F. Aswad, M. Minagawa, S. Govindarajan, and G. Dennert. 2006. P2X7 receptors regulate NKT cells in autoimmune hepatitis. J. Immunol. 176: 2152-2160. (Pubitemid 43201662)